Toby T. Hecht

National Cancer Institute — Malaysia

Medicine · Health Sciences

16h-index2.7kcitations40works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(12), Immunotherapy and Immune Responses(8), T-cell and B-cell Immunology(5), Immune Cell Function and Interaction(5), Virology and Viral Diseases(5)

Publications40 total

The Diverse Aspects of Uterine Serous Cancer: an NCI workshop on the status of and opportunities for advancement of research
JNCI Journal of the National Cancer Institute·2024Open Access
Supplementary Data from The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2023Open Access
Data from The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2023Open Access
Data from The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2023Open Access
Supplementary Data from The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2023Open Access
The NCI Glioblastoma Therapeutics Network (GTN)
Neuro-Oncology·2022· 1 citedOpen Access
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Clinical Cancer Research·2019· 368 citedOpen Access
A multiplex immunofluorescence assay to assess immune checkpoint inhibitor-targeted CD8 activation and tumor colocalization in FFPE tissues.
Journal of Clinical Oncology·2019· 6 cited
Excellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies
Molecular Oncology·2015· 12 citedOpen Access
LGL-1: A Nonpolymorphic Antigen Expressed on a Major Population of Mouse Natural Killer Cells
2015· 83 cited
Sport Programs and Transcational Research in Cancer
WORLD SCIENTIFIC eBooks·2014
Purification of clinical-grade disulfide stabilized antibody fragment variable—Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli
Applied Microbiology and Biotechnology·2012· 15 cited
Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
Journal of Clinical Oncology·2010· 238 citedOpen Access
Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
Annals of Oncology·2010· 19 citedOpen Access
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Clinical Cancer Research·2009· 1.4k citedOpen Access
Anti-neuroblastoma activity of hu14.18-IL2 against minimal residual disease in a Children’s Oncology Group (COG) phase II study
Journal of Clinical Oncology·2008· 18 cited
Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor β antibody (HuMikβ1), and correlation with functional activity using an antigen-transfected murine cell line
Journal of Immunological Methods·2006· 7 cited
Host Conditioning Is a Primary Determinant in Modulating the Effect of IL-7 on Murine Graft-versus-Host Disease
The Journal of Immunology·2004· 40 citedOpen Access
Production and purification of refolded recombinant human IL-7 from inclusion bodies
Protein Expression and Purification·2003· 32 cited
Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.
PubMed·1990· 35 cited
page 1 of 2Next →

Frequent Co-authors

James P. Allison(5), Andrea Stern Ferris(5), Olivera J. Finn(5), Benjamin M. Hastings(5), Ira Mellman(5), Sheila A. Prindiville(5), Jaye L. Viner(5), Louis M. Weiner(5), Lynn M. Matrisian(5), John R. Wunderlich(4), David M. Segal(4), Donald F. Summers(4), Martin A. Cheever(4), David F. Winkler(3), Steven L. Giardina(3), Andrew M. Hruszkewycz(2), Abdul Tawab-Amiri(2), Suzanne Shusterman(2), Jacquelyn A. Hank(2), John M. Maris(2)